Compass Pathways' Corporate Minority Round

Compass Pathways raised a round of funding on October 03, 2018. Investors include Atai Life Sciences.

Compass Pathways' initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression. …

Articles about Compass Pathways' Corporate Minority Round: